- conflicts or gaps
- [{"employee_count_discrepancy": {"value": "YC lists 6 employees; SBIR portfolio lists 8; Tracxn lists 13 (Apr 2026). Sources disagree.", "source_urls": ["https://www.ycombinator.com/companies/aesculatech", "https://www.sbir.gov/portfolio/1312153", "https://tracxn.com/d/companies/aesculatech/__yMR6Wkl2YM7Mb4DWtwj498Zn8-XhtfYhucbvpsQv2n8"]}, "founder_ceo_role_history": {"value": "USC 2016 articles name Andrew Bartynski CEO; TechCrunch 2018 names Bayat chief science officer and Bartynski CEO in places; YC 2026 lists only Niki Bayat as Founder/CEO (Andrew absent from YC founder section).", "source_urls": ["https://viterbischool.usc.edu/news/2016/11/a-better-way/", "https://techcrunch.com/2018/03/19/biomedical-startup-aesculatech-is-creating-a-new-more-patient-friendly-drug-delivery-system/", "https://www.ycombinator.com/companies/aesculatech"]}, "co_founder_current_involvement": {"value": "Andrew Bartynski confirmed co-founder in historical press but not on YC page; third-party directory (MarketScreener) lists him as AesculaTech CEO while also CEO of Kopra Bio since 2024 — current operational role unverified on official company site.", "source_urls": ["https://www.ycombinator.com/companies/aesculatech", "https://techcrunch.com/2018/03/19/biomedical-startup-aesculatech-is-creating-a-new-more-patient-friendly-drug-delivery-system/", "https://in.marketscreener.com/insider/ANDREW-BARTYNSKI-A2S2VI/"]}, "funding_total_reporting_gap": {"value": "CB Insights/Craft/Tracxn aggregate ~$120K VC; NIH SBIR alone totals ~$1.47M — public databases undercount total non-dilutive funding.", "source_urls": ["https://www.cbinsights.com/company/aescula-tech/financials", "https://www.sbir.gov/portfolio/1312153", "https://craft.co/aesculatech"]}, "funding_round_count_discrepancy": {"value": "CB Insights reports 6 funding rounds; Tracxn reports 3 rounds.", "source_urls": ["https://www.cbinsights.com/company/aescula-tech/financials", "https://tracxn.com/d/companies/aesculatech/__yMR6Wkl2YM7Mb4DWtwj498Zn8-XhtfYhucbvpsQv2n8"]}, "product_naming_inconsistency": {"value": "Humidifeye / HUMIDIFEYE / HumidifEye used interchangeably; platform material called AesculaGel in some sources and 'smart material platform' in others.", "source_urls": ["https://aesculatech.com/meet-humidifeye/", "https://www.cbinsights.com/company/aescula-tech", "https://aesculatech.com/about-us/", "https://www.ycombinator.com/companies/aesculatech"]}, "commercial_timeline_slippage": {"value": "TechCrunch (Mar 2018) projected Humidifeye commercially available by 2019; company website still marks device investigational in 2026; Nov 2023 press release targeted 2024 market clearance — no public FDA clearance confirmation found.", "source_urls": ["https://techcrunch.com/2018/03/19/biomedical-startup-aesculatech-is-creating-a-new-more-patient-friendly-drug-delivery-system/", "https://aesculatech.com/meet-humidifeye/", "https://www.cbinsights.com/company/aescula-tech"]}, "initial_indication_shift": {"value": "Early USC coverage emphasized glaucoma timed-release drops; company pivoted focus to dry eye syndrome as first commercial product.", "source_urls": ["https://viterbischool.usc.edu/news/2016/11/a-better-way/", "https://techcrunch.com/2018/03/19/biomedical-startup-aesculatech-is-creating-a-new-more-patient-friendly-drug-delivery-system/"]}, "yc_founders_list_incomplete": {"value": "YC company page lists Niki Bayat twice as sole active founder; does not include Andrew Bartynski despite multiple independent co-founder citations.", "source_urls": ["https://www.ycombinator.com/companies/aesculatech", "https://techcrunch.com/2018/03/19/biomedical-startup-aesculatech-is-creating-a-new-more-patient-friendly-drug-delivery-system/"]}, "tracxn_founder_list_gap": {"value": "Tracxn lists only Niki Bayat as founder/CEO; omits Andrew Bartynski.", "source_urls": ["https://tracxn.com/d/companies/aesculatech/__yMR6Wkl2YM7Mb4DWtwj498Zn8-XhtfYhucbvpsQv2n8", "https://viterbischool.usc.edu/news/2016/11/a-better-way/"]}}]
- source urls
- ["https://aesculatech.com/", "https://aesculatech.com/about-us/", "https://aesculatech.com/meet-humidifeye/", "https://craft.co/aesculatech", "https://in.marketscreener.com/insider/ANDREW-BARTYNSKI-A2S2VI/", "https://techcrunch.com/2018/03/19/biomedical-startup-aesculatech-is-creating-a-new-more-patient-friendly-drug-delivery-system/", "https://today.usc.edu/usc-viterbi-startup-aims-to-make-it-easier-for-glaucoma-patients-to-take-eye-drops/", "https://tracxn.com/d/companies/aesculatech/__yMR6Wkl2YM7Mb4DWtwj498Zn8-XhtfYhucbvpsQv2n8", "https://viterbischool.usc.edu/news/2016/11/a-better-way/", "https://www.cbinsights.com/company/aescula-tech", "https://www.cbinsights.com/company/aescula-tech/financials", "https://www.inknowvation.com/sbir/companies/aesculatech-inc", "https://www.mystrategist.com/blog/article/s2e10_-_aesculatech_reverse_chocolate_for_dry_eye.html", "https://www.sbir.gov/awards/202945", "https://www.sbir.gov/awards/219590", "https://www.sbir.gov/portfolio/1312153", "https://www.ycdb.co/company/aesculatech", "https://www.ycombinator.com/companies/aesculatech"]